| Literature DB >> 34150637 |
Waseem Masalha1,2, Dieter Henrik Heiland1,2, Christine Steiert1,2, Marie T Krüger1,2,3, Daniel Schnell2,4,5, Christian Scheiwe1,2, Oliver Schnell1,2, Anca-L Grosu2,4,5, Jürgen Beck1,2, Jürgen Grauvogel1,2.
Abstract
OBJECTIVE: Spheno-orbital meningiomas (SOM) are rare intracranial tumors that arise at the sphenoid wing. These tumors can invade important neurovascular structures making radical resection difficult, while residual tumors often lead to recurrence. The purpose of this study was to evaluate prognostic factors influencing the recurrence and progression-free survival (PFS) rates of spheno-orbital meningiomas, with a particular focus on the role of surgery and postoperative radiotherapy.Entities:
Keywords: meningioma; postoperative radiotherapy; progression-free survival; spheno-orbital meningioma; surgery
Year: 2021 PMID: 34150637 PMCID: PMC8212033 DOI: 10.3389/fonc.2021.672228
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1(A) Flow diagram of included patients with spheno-orbital meningioma from our database. (B) Kaplan-Meier curve for progression-free survival based on tumor location. (C) Kaplan-Meier curve for progression-free survival based on extent of resection. (D) Kaplan-Meier curve for progression-free survival based on Therapy (Surgery only vs. surgery plus radiotherapy).
Patient data.
| Parameter | Surgery N=50 | Surgery plus Radiotherapy N=15 | |
|---|---|---|---|
|
| 56.98 ± 12.52 | 48.41 ± 10.03 |
|
|
| 39 (78%) | 11 (73%) | p=0.73** |
|
| 24 (31%) | 2 (3%) |
|
|
| 80.2 ± 11.69 | 82 ± 8.61 | p=0.52* |
|
| 80.7 ± 12.69 | 80.6 ± 7.03 | p=0.98* |
|
| 40 (80%) | 12 (80%) | p=1** |
|
| 36 (72%) | 10 (66.6%) | P=0.75** |
|
| 38 (76%) | 9 (60%) | p=0.32** |
*T-Test.
**Fisher´s exact test.
***Chi-squared test.
KPS, Karnofsky Performance scale.
CI, Confidence interval.
GTR, Gross total resection.
STR, subtotal resection.
SD, Standard-deviation.
Cox regression analysis.
|
|
|
| ||
|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |
| Univariate analysis | Multivariate analysis | |||
|
| 0.62(0.26-1.4) | 0.27 | ||
|
| 0.52(0.21-1.3) | 0.14 | ||
|
|
|
|
|
|
|
| 1.2(0.45-3.3) | 0.7 | 2.5(0.86-7.3) | 0.09 |
|
| 2.1(0.93-4.9) | 0.074 | ||
|
| 0.97(0.42-2.2) | 0.94 | ||
|
| 0.47(0.19-1.2) | 0.11 | ||
|
|
|
|
|
|
|
| 1.5(0.66-3.6) | 0.32 | ||
GTR, Gross total resection.
STR, subtotal resection.
CI, Confidence interval.
HR, Hazard ratio.
KPS, Karnofsky Performance scale.
Postoperative cranial nerve deficits.
| Cranial Nerve | Postoperative permanent deficits (N, %) | GTRN=26 | STRN=39 | p-value |
|---|---|---|---|---|
| I c.n | 1(1.5%) | 0 | 1 | p=1** |
| II c.n | 11(15%) | 4 | 7 | p=0,72** |
| III c.n | 9(13%) | 3 | 6 | p=0,73** |
| IV c.n | 4(6%) | 0 | 4 | p=0,14** |
| V c.n | 10(15%) | 8 | 2 |
|
| VI c.n | 11(15%) | 4 | 7 | p=0,72** |
c.n, cranial nerve.
GTR, Gross total resection.
STR, subtotal resection.
HR, Hazard ratio.
**Fisher´s exact test.
Visual acuity and proptosis after surgery at last examination.
| Worse (N, %) | Stable (N, %) | Improved (N, %) | |
|---|---|---|---|
|
| 11 (17%) | 51 (79%) | 3 (4%) |
|
| 2 (3%) | 9 (14%) | 54 (83%) |